Image 12_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif by Yaping Chu (789771)

Table 1_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.docx by Yaping Chu (789771)

Image 14_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif by Yaping Chu (789771)

Image 1_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif by Yaping Chu (789771)

Image 11_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif by Yaping Chu (789771)

Image 16_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif by Yaping Chu (789771)

Image 13_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif by Yaping Chu (789771)

Image 3_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif by Yaping Chu (789771)

Image 15_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif by Yaping Chu (789771)

Image 2_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif by Yaping Chu (789771)

Image 10_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif by Yaping Chu (789771)

Projected global leukemia burden, 1990-2050. by Chengjun Hu (588206)

“…Conclusion: Although there has been a marked decrease in global leukemia incidence, mortality, and DALYs over the past 31 years, the rise in new cases due to population growth suggests an increasing overall disease burden by 2050. …”

Correlation between HDI and EAPC. by Chengjun Hu (588206)

“…Conclusion: Although there has been a marked decrease in global leukemia incidence, mortality, and DALYs over the past 31 years, the rise in new cases due to population growth suggests an increasing overall disease burden by 2050. …”

Global leukemia incidence and EAPC, 1990-2021. by Chengjun Hu (588206)

“…Conclusion: Although there has been a marked decrease in global leukemia incidence, mortality, and DALYs over the past 31 years, the rise in new cases due to population growth suggests an increasing overall disease burden by 2050. …”

Bluetooth beacons with colour coded lanyards. by J Mark Ansermino (13958512)

Online travelogues information from Ctrip. by Weiya Zhang (346410)

“…Findings indicate that: (1) Locations mentioned in Tang and Song poetry show significant spatial differentiation, with urban areas displaying a clustered distribution and suburbs showing scattered hotspots. (2) The number of locations referenced in Song poetry increased significantly compared to Tang poetry, suggesting that Nanjing’s economic growth heightened the city’s appeal and inspired more literary output. (3) Song Dynasty poetry reflects a shift toward more neutral and negative emotions, with a marked decrease in positive expressions. …”

Raw data for HCs. by Beshir Bedru Nasir (8218863)

“…Additionally, there was a 10% increase in the proportion of extra-pulmonary TB cases. …”

Raw data for hospitals. by Beshir Bedru Nasir (8218863)

“…Additionally, there was a 10% increase in the proportion of extra-pulmonary TB cases. …”

Raw data. by Beshir Bedru Nasir (8218863)

“…Additionally, there was a 10% increase in the proportion of extra-pulmonary TB cases. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …”